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0.138, p=O.O64). NT-pro-BNP correlated with mitral valve E/A ratio (r=0.243, p=O.OOl) 
but not isovolumetric relaxation time (r=0.044. NS) or deceleration time (r=-0.044, NS). 
NT-pro-BNP remained correlated to E/A-ratio (p=O.195, p<O.Ol) with adjustment for cir- 
cumferential end-systolic stress. However, when taking LV mess and wall stress into 
account there was only a trend towards a relation between NT-pro-BNP and mitral valve 
E/A ratio (&0.133, p=O.O71). Change in NT-pro-BNP during 1 year of treatment did not 
correlate with changes in EFS (r=-0.040), MWS (r=-0.074), E/A-ratio (r=O.O08), isovolu- 
mic relaxation time (r=-0.04) or mitral valve e-point deceleration time (r=O.O37. all NS). 
Conclusion: NT-pro-BNP maybe related to LV contractiliy and filling independent of LV 
mass and wall stress in hypertensive patients with ECG LV hypertrophy at baseline. 
However, there was no wall-stress-independent relation between NT-pro-BNP and LV 
pump function. Furthermore, change in NT-pro-BNP over time was not related to 
changes in LV function. 
1038-73 Heart Failure in the Community and in Hospitals: 
Selection and Survival of Patients in Different Settings 
Federica De Giuli. Marlin R. Cowie, Kay-Tee Khaw, Goerge C. Sutton, Roberto Ferrari, 
Philip A. Poole-Wilson, S. Maugeri Foundation IRCCS, Gussago (BS), Italy, NHLI, 
London, United Kingdom 
The aim of the study was to compare the characteristics and 3.year survival data of 
patients (Pts) with diagnosis of heart failure (HF) made in the community and in hospitals 
ln the UK. Methods: Three populations (>=45years) were studied: HFa, 6478 pts from 
the General Practice Research Database (with data from 696884 persons) with new HF 
diagnosis clearly stated by 525 GPs, according to their clinical judgment; HiIHF, 225 Pts 
from the Hillingdon study, with new HF diagnosis made by an expert panel of cardiolo- 
gists, applying the ESC criteria; NetHF, 1929 Pts screened for the Network trial, with HF 
diagnosis confirmed by hospital cardiologists according to their clinical judgment. Stan- 
dardized mortality ratio (SMR) at 1 -year was calculated using as reference population the 
1994 UK age and sex specific death rates (the reference population being l).Results: 
Incidence rates (cases/l000 person-years) were 9.6 and 8.9 in HFa and 3.7 and 4.7 in 
HiIHF, I” women and men, respectively. NetHF were mostly chronic cases. Proportions 
of women were 55.5, 47.1 and 37.5 in HFa, HilHF and NetHF, respectively (’ p.zO.02, 
fp<O.OOl. $pcO.Ol). Mean survival (months-95%CI) was 23.8 (23.4-24.1) for HFa. 21.7 
(19.6-23.7) for HilHF and 31.8 (31.3-32.3) for NetHF(’ p=O.25, f < 0.001, $cO.OOl).. l- 
year SMR (95% Cl) was 14.7 (13.9-15.7) for HFa, 15.2 (11.1-20.7) for HilHF and 3.2 
(2.4-4.3) for NetHF. Both HFa and HilHF (incident cases) had en especially high mortality 
in the first 3 months of follow-up that was not seen in NetHF (chronic cases).Conclu- 
sions: There is a descending rank order I” mean age and proportion of wmen in HF Pts 
seen in the community, in hospitals and those screened for trials. Chronic ceses, which 
are usually studled in trials, represent survivors from the high mortality observed in the 
first 3 months after diagnosis. Both the clinical judgment of GPs and the rigorous applica- 
tion of ESC criteria seem to lead to the detection of severe cases with similar survival in 
both absolute terms and in shape of the survival culves.(’ indicates HFa vs. HiIHF; f, 
HFa vs. NetHF; $, HilHF vs. NetHF). 
1038-74 Does the Prevalence of Atrial Fibrillation Vary by Race 
in Patients With Heart Failure? The Epidemiology, 
Practice, Outcomes, and Costs of Heart Failure 
(EPOCH) Study 
Bernice Rue Angela M. Capra, Nancy G. Jensvold, Alan S. Go, Veterans Administration -I 
Medical Center, San Francisco, San Franc~sco, CA, Kaiser Permanente, Oakland, CA 
Background: The association between heart failure (HF) and atrial fibrillation (AF) is 
well known but the risk factors predisposing to AF in the setting of HF are not well under- 
stood. It has been postulated that among patients with HF, blacks may have a lower 
prevalence of AF compared with whites, but this has not been clearly defined along with 
the potential factors that may explain any observed racial difference. 
Methods: We performed a cross-sectional analysis of the association between race and 
AF in a random sample of adults hospitalized with HF (July 1999.June 2000). HF was 
confirmed using Framingham Heart Study criteria. Data on demographic characteristics, 
comorbid conditions, vital signs at presentation. prior medication use, and left ventricular 
systolic function status were obtained from medical records and automated databases. 
Prevalent AF was defined as AF or atrial flutter documented by electrocardiogram during 
hospitalization and/or by medlcal history. We assessed the independent relationship 
between race and AF using multivariable logistic regression. 
Results: Among 1373 patients (223 blacks, 1150 white) hospitalized with confirmed HF, 
the prevalence of AF was 34.0% (95% Cl: 31.4% to 36.4%). Blacks were more likely than 
whites to be younger (mean age 67 vs. 74 yrs, P<O.OOl) and to have hypertension 
(75.3% vs. 62.4%, P<O.OOl) and prior HF (64.6% vs. 54.9%, P<O.Ol). Blacks were also 
less likely to have a history of coronary disease, hypothyroidism, valve replacement, or 
revascularization, or to be taking digoxin or a beta-blocker on admission. Blacks had a 
significantly lower prevalence of AF (19.7%) compared with whites (38.3%, P<O.OOl). 
After adjustment for nsk factors for AF and other potential confounders, blacks had 35% 
decreased odds of having AF (adjusted odds ratio 0.65, 95% Cl: 0.43-0.97) compared 
with whites. 
Conclusion: In a large contemporary cohort of adults with heart failure, atrial fibrillatwm 
was a c~mrn~n complication but was significantly less ccmrn~n among blacks compared 
with whites. Ractal variation was not explaIned by differences in traditional risk factors for 
atrial fibrillation, presumed heart failure etiology or severity, or medical management. 
1038-75 Sex Differences in Heart Failure: Report From a Large 
Community-Based Cohort 
Edward F. Philbin. 111 Donna Phelan. Mikhail Torosoff. Albany Medical College, Albany, 
NY 
Background: The extent to which wmen differ from men with respect to clinical presen- 
tation, treatment and outcomes in heart failure (HF) is debated. 
Methods: We queried a HF registry compiled from consecutive HF admissions to IO 
community hospitals. Demographics, clinical characteristics, treatment variables and out- 
comes were compared by sex. 
Results: Vital status 6 months after hospital admission was known for 2,506 patients. Of 
these, 1,304 (56%) were women. Mean functional class at admission and the prevalence 
of atrial fibrillation and prior HF were equivalent. Women were older (77.1 vs 73.6 years), 
more often nursing home residents (17 vs 9%) and less often received care from cardiol- 
ogists (14 vs 20%). Women had higher mean ejection fraction (0.39 vs 0.32) and more 
often had diastolic HF (52 vs 34%). lschemic cause of HF was documented less often 
among women (31 vs 43%). Women had lower mean serum creatinine and hematocrit. 
Women received catheterization (10 vs 14%), exercise testing (8 vs 11%) and coronary 
revascularization (4 YS 7%) less often (all PcO.05). Other diagnostic studies were per- 
formed equally. At discharge women less often received ACE inhibitors (57 vs 63%) and 
digoxin (49 vs 54%). Hospital stay was longer for women (7.5 vs 6.9 days) (all P<O.O5). 
Hospital mortality was equivalent (8.5 vs 6.0%). Women were less likely to die during the 
6 months following discharge (15.2 vs 18.4%, P=O.O3). Thus, crude 6.month mortality 
trended lower among women (21.3 YS 24.0%, P=O.lZ). Sex was borderline predictive of 
better survival using the Kaplan-Meier method (P=O.ll) and a proportional hazards 
model to account for age and other factors (P=O.l9). In follow-up, wmen were slightly 
less likely to have rehospitalization for HF (24 vs 26%, P=O.27) or any cause (42 YS 45%, 
P=O.O9). The combined endpoint of death or readmission occurred less often among 
women (52 “s 57%, P=O.O2). 
Conclusions: In this community-based HF cohort, clear sex-related trends emerge. 
Women are older and mcxe often have diastolic HF. They receive a different standard of 
care with respect to medications and referral to specialists. In spite of this, women have 
comparable or better clinical outcomes during and after hosptialization for HF. 
1038-76 Gender-Related Differences in Neurohormonal Plasma 
Levels 
Sylvie A. Ahn, Ronald Van Beneden, Jean-Marie Ketelslegers, Hubert G. Pouleur Michel I- 
F. Rousseau University of Louvain, Brussels, Belgtum -I 
Background :Age is known to affect plasma concentrations of cardiac neurohormonal 
markers used in the evaluation of congestive heart failure, but little is known about gen- 
der-related effects. 
Methods :Accordingly, we compared the plasma levels of atrial natriuretic peptide (N- 
proANF), brain natriuretic peptide (BNP), big endothelin-1 (big ET-l) and angiotensln II 
(All) in 92 healthy subjects (46 females, age 30 to 70 years; 46 males, age 30 to 69 
years). Except for oral contraceptive or hormone replacement therapy, no subject was 
taking chronic medication. 
Results :Overall, mean plasma levels of N-proANF (322 vs 259’ pg/mL). BNP (6.3 YS 
4.5’* pg/mL) were higher in women than in men, while All levels were higher in men 
(10.1 vs 13.5’ pg/mL). Plasma levels of big ET-1 were similar in both groups (4.3 vs 4.1 
pg/mL). 
However, when stratified for age (c or > 50 years), it appears that the increase in natri- 
uretic peptides in women becomes mire evident with aging, while the reverse is true for 
All in men. By contrast, big ET-1 levels seem unaffected by age (see table). 
COnChSiOn :Normal values of N-proANF, BNP and All are affected by age and sex. 
These variations are to be taken into account when using neurohormonal cardiac mark- 
ers for diagnostic purpose. In this perspective, changes in big ET-l, which is more stable 
accr~ss gender and age, should be easier to interpret. 
Data (pg/mL) are means (*SD); *p<O.OS, **p<O.Ol 
N Age N-proANF BNP Big Et-l All 
Male <50 
Female ~50 
Male >50 
Female >50 
24 38*6 230+85 3.9*0.7 4.li7.0 13.0’+5.3 
23 40+6 242+64 4.3tl.l 4.4-0.8 10.0*4.5 
22 58*5 292*117 5.2+2.2 4.2zto.9 14.1+8.0 
23 60+6 402’*174 8.3”*2.4 4.lztO.7 10.5*7.5 
1038-77 The Prevalence of Diastolic Heart Failure in the 
Community 
Gawn I. Galasko, Roxy Senior, Avijtt Lahiri. Northwick Park Hospital, London, United 
Kingdom 
Background Heart failure is placing an increasing burden on the community. The Euro- 
pean Study Group on Diastolic Heart Failure has recently Issued guidelines for the diag- 
nosis of diastolic heart failure (DHF) (EurHeatiJ 1998. 19: 990), which may underlie up 
to 50% of all cases. No studies have looked at the prevalence of DHF in the community 
using these criteria. Accordingly this study was undertaken to assess this further in a 
community in North London. Methods 1403 subjects 245 years old were chosen at rsn- 
dom from 7 representative general practices and invited to undergo a questionnaire, clin- 
ical examination, ECG. echocardiogram and plasma N-terminal-proBNP (NTB) levels 
(Elecys, Roche Diagnostics). DHF was diagnosed according to criteria set by the Study 
Group namely all three of: symptoms of congestive heart failure in the absence of signifi- 
cant lung disease andfor signs of congestive heart failure; left ventricular ejection fraction 
